Julio Pascual
Julio Pascual
Department of Nephrology, Hospital del Mar. Department of Nephrology, Hospital Ramón y Cajal
Verified email at psmar.cat
Cited by
Cited by
European Renal Best Practice Guideline on kidney donor and recipient evaluation and perioperative care
D Abramowicz, P Cochat, FHJ Claas, U Heemann, J Pascual, C Dudley, ...
Nephrology Dialysis Transplantation 30 (11), 1790-1797, 2015
Causes and prognosis of acute renal failure in the very old
J Pascual, F Liaño, Madrid Acute Renal Failure Study Group
Journal of the American Geriatrics Society 46 (6), 721-725, 1998
Everolimus plus early tacrolimus minimization: a phase III, randomized, open‐label, multicentre trial in renal transplantation
RM Langer, R Hené, S Vitko, M Christiaans, H Tedesco‐Silva Jr, ...
Transplant International 25 (5), 592-602, 2012
A systematic review on steroid withdrawal between 3 and 6 months after kidney transplantation
J Pascual, C Galeano, A Royuela, J Zamora
Transplantation 90 (4), 343-349, 2010
The changing trends and outcomes in renal replacement therapy: data from the ERA-EDTA Registry
M Pippias, KJ Jager, A Kramer, T Leivestad, MB Sánchez, FJ Caskey, ...
Nephrology Dialysis Transplantation 31 (5), 831-841, 2016
Characterization of ACE and ACE2 expression within different organs of the NOD mouse
H Roca-Ho, M Riera, V Palau, J Pascual, MJ Soler
International journal of molecular sciences 18 (3), 563, 2017
Delayed graft function does not reduce the survival of renal transplant allografts
R MarcÉn, L Orofino, J Pascual, MA de la Cal, JL Teruel, JJÉ Villafruela, ...
Transplantation 66 (4), 461-466, 1998
Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?
M Crespo, A Torio, V Mas, D Redondo, MJ Pérez-Sáez, M Mir, A Faura, ...
Transplant immunology 29 (1-4), 28-33, 2013
Everolimus therapeutic concentration range defined from a prospective trial with reduced-exposure cyclosporine in de novo kidney transplantation
JM Kovarik, H Tedesco, J Pascual, G Civati, MN Bizot, J Geissler, ...
Therapeutic drug monitoring 26 (5), 499-505, 2004
Very early steroid withdrawal or complete avoidance for kidney transplant recipients: a systematic review
J Pascual, A Royuela, C Galeano, M Crespo, J Zamora
Nephrology Dialysis Transplantation 27 (2), 825-832, 2012
Post-transplant lymphoproliferative disorder—the potential of proliferation signal inhibitors
J Pascual
Nephrology Dialysis Transplantation 22 (suppl_1), i27-i35, 2007
Everolimus with reduced calcineurin inhibitor exposure in renal transplantation
J Pascual, SP Berger, O Witzke, H Tedesco, S Mulgaonkar, Y Qazi, ...
Journal of the American Society of Nephrology 29 (7), 1979-1991, 2018
Cardiovascular and noncardiovascular mortality among men and women starting dialysis
JJ Carrero, DJ de Jager, M Verduijn, P Ravani, J De Meester, JG Heaf, ...
Clinical Journal of the American Society of Nephrology 6 (7), 1722-1730, 2011
Trends in dialysis modality choice and related patient survival in the ERA-EDTA Registry over a 20-year period
MWM van de Luijtgaarden, KJ Jager, M Segelmark, J Pascual, F Collart, ...
Nephrology Dialysis Transplantation 31 (1), 120-128, 2016
Novel views on new-onset diabetes after transplantation: development, prevention and treatment
M Hecking, J Werzowa, M Haidinger, WH Hörl, J Pascual, K Budde, ...
Nephrology Dialysis Transplantation 28 (3), 550-566, 2013
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
HJL Heerspink, HH Parving, DL Andress, G Bakris, R Correa-Rotter, ...
The Lancet 393 (10184), 1937-1947, 2019
Home-based pulmonary rehabilitation in very severe COPD: is it safe and useful?
AM Fernández, J Pascual, C Ferrando, A Arnal, I Vergara, V Sevila
Journal of cardiopulmonary rehabilitation and prevention 29 (5), 325-331, 2009
Everolimus (Certican) in renal transplantation: a review of clinical trial data, current usage, and future directions
J Pascual, IN Boletis, JM Campistol
Transplantation reviews 20 (1), 1-18, 2006
Early interdisciplinary hospital intervention for elderly patients with hip fractures: functional outcome and mortality
FJ Tarazona-Santabalbina, Á Belenguer-Varea, E Rovira-Daudi, ...
Clinics 67 (6), 547-556, 2012
Use of proliferation signal inhibitors in the management of post-transplant malignancies—clinical guidance
JM Campistol, J Albanell, W Arns, I Boletis, J Dantal, JW De Fijter, ...
Nephrology Dialysis Transplantation 22 (suppl_1), i36-i41, 2007
The system can't perform the operation now. Try again later.
Articles 1–20